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Substance P Enhances the Production of Interferon-induced
Protein of 10 kDa by Human Keratinocytes in Synergy with
Interferon-c
Naoko Kanda and Shinichi Watanabe
Department of Dermatology,Teikyo University, School of Medicine,Tokyo, Japan
A neuropeptide substance P is related to skin in£amma-
tion. Interferon-induced protein of 10 kDa (IP-10) che-
moattracts T helper 1 cells, and interferon-induced
protein of 10 kDa production by keratinocytes is en-
hanced in in£ammatory skin diseases such as psoriasis.
We examined the in vitro e¡ects of substance P on inter-
feron-induced protein of 10 kDa production by human
keratinocytes.Though substance P alone did not induce
interferon-induced protein of 10 kDa production, it
enhanced interferon-induced protein of 10 kDa secre-
tion, mRNA expression, and promoter activity induced
by suboptimal concentrations of interferon-c. Interfer-
on-stimulated response element and two nuclear fac-
tor-jB sites on interferon-induced protein of 10 kDa
promoter were responsible for the enhancement by sub-
stance P. Substance P alone enhanced transcriptional
activity and transcription factor binding through the
two nuclear factor-jB sites, whereas it did not alter in-
terferon-c-induced transcriptional activity and tran-
scription factor binding through interferon-stimulated
response element.The e¡ects of substance P on interfer-
on-induced protein of 10 kDa production and nuclear
factor-jB activation were inhibited by neurokinin-1 re-
ceptor antagonist, phospholipase C inhibitor, intracellu-
lar Ca2+ chelator, and anti-oxidant.These results suggest
that substance P may induce nuclear factor-jB activa-
tion and interferon-induced protein of 10 kDa produc-
tion in synergy with interferon-c via neurokinin-1
receptor on keratinocytes. These e¡ects of substance P
may be mediated via phospholipase C activation, intra-
cellular Ca2+ signal, and reactive oxygen intermediates.
Key words: nuclear factor-kB/reactive oxygen intermediates
and Ca2+. J Invest Dermatol 119:1290 ^1297, 2002
I
t is known that neuropeptides regulate in£ammatory reac-
tions (Ansel et al, 1996). Substance P (SP) is a tachykinin fa-
mily neuropeptide and is released from the sensory C-¢ber
endings (Ansel et al, 1996). SP induces the synthesis of
proin£ammatory cytokines, such as interleukin-6, tumor
necrosis factor-a, or interleukin-12 in monocyte/macrophages
(Lotz et al, 1988; Kincy-Cain and Bost, 1997), induces histamine
release from mast cells (Schanahan et al, 1985), and the expression
of cell adhesion molecules in endothelial cells (Quinlan et al, 1998,
1999b). SP binds to guanine nucleotide-binding protein-coupled
neurokinin-1 receptor (NK-1R) on membranes of various cells.
SP binding to NK-1R activates phospholipase C and generates
inositol 1,4,5-triphosphate and diacylglycerol (Fig 1). Inositol
1,4,5-triphosphate increases intracellular Ca2þ concentration,
which induces the formation of reactive oxygen intermediates
(ROI), whereas diacylglycerol activates protein kinase C, which
promotes the activities of mitogen-activated protein kinases
(Fig 1) (Lieb et al, 1997; Fiebich et al, 2000). SP binding to
NK-1R also activates adenylate cyclase and generates cyclic ade-
nosine monophosphate signal, which activates protein kinase A
(Christian et al, 1994). These SP-induced intracellular signaling
pathways lead to the activation of various transcription factors;
Ca2þ signal activates nuclear factor of activated T cells (Quinlan
et al, 1999a), ROI activates nuclear factor kB (NF-kB) (Lieb et al,
1997), mitogen-activated protein kinases activate nuclear factor of
interleukin-6 or activator protein 1 (Fiebich et al, 2000), and pro-
tein kinase A activates cyclic adenosine monophosphate response
element binding protein (Christian et al, 1994). The SP-induced
signaling pathways thus promote the gene expression dependent
on these transcription factors (Christian et al, 1994; Quinlan et al,
1999a).
Previous studies suggest the relationship between SP and in-
£ammatory skin diseases, such as psoriasis (Naukkanrinen et al,
1989; Eedy et al, 1991), contact dermatitis (Scholzen et al, 2001), or
photodermatitis (Scholzen et al, 1999). Psoriasis-related reports are
con£icting, however; some studies show the increased amounts of
SP in psoriatic skin lesions (Naukkanrinen et al, 1989; Eedy et al,
1991), whereas others show nonaltered or rather reduced amounts
of SP in those lesions (Anand et al, 1991; Pincelli et al, 1992).
The lymphocytes in¢ltrating into psoriatic lesions are predomi-
nantly activated T helper 1 cells (Bos and de Rie, 1999), indicating
the involvement of chemokines attracting those cells. Interferon-
induced protein of 10 kDa (IP-10) is a member of the CXC
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chemokine family and preferentially attracts activated T helper 1
cells through the cell surface CXC chemokine receptor 3 (Ka-
plan, 2001). Keratinocytes can produce IP-10 in response to inter-
feron (IFN)-g (Boorsma et al, 1998), and the expression of IP-10 is
enhanced in keratinocytes of in£ammatory skin diseases, such as
psoriasis (Rottman et al, 2001), contact dermatitis (Flier et al, 1999),
or delayed type hypersensitivity reaction (Kaplan et al, 1987).
T helper 1 cells in¢ltrating into these skin lesions may produce
IFN-g, which induces IP-10 production by keratinocytes, and
the produced IP-10 in turn attracts activated T helper 1 cells into
the lesional skin. Such a positive feedback loop of IFN-g/IP-10
may sustain the T helper 1-mediated skin in£ammation. As SP
acts on keratinocytes and enhances their synthesis of cytokines
or cell adhesion molecules related to skin in£ammation (Viac
et al, 1996), it is hypothesized that SP may also enhance IP-10 pro-
duction by keratinocytes. Besides the recent study reports that SP
potentiates IFN-g-induced major histocompatibility complex
class II expression in rat microglia (McCluskey and Lampson,
2001), indicating the synergy between SP and IFN-g. It is thus
anticipated that SP may also potentiate the IFN-g-induced IP-10
production by keratinocytes; however, it has not been precisely
investigated if SP may enhance IP-10 production in keratinocytes,
either alone or in combination with IFN-g.
In this study, we examined the in vitro e¡ects of SP on IP-10
production by human keratinocytes.We found that SP enhanced
their IP-10 production in synergy with low levels of IFN-g at the
transcriptional level. We further analyzed the cis-regulatory ele-
ments responsible for the SP-induced IP-10 transcription.
MATERIALS AND METHODS
Reagents SP, phorbol-12-myristate 13-acetate, pyrrolidine dithiocarbamate
(PDTC), and calphostin C were obtained from Sigma (St Louis, MO).
GR82334, MEN10207, and [Trp7, b-Ala8]neurokinin A-(4^10) were
purchased from Peninsula Laboratories (Belmont, CA). 1,2-bis(2-amino-
phenoxy)ethane-N,N,N 0,N 0-tetraacetic acid acetoxymethyl ester (BAPTA-
AM), U73122, PD98059, SB202190, and SQ22536 were obtained from
Calbiochem (La Jolla, CA). Recombinant human IFN-g was purchased
from R&D (Minneapolis, MN). Antibodies used in the electrophoretic mobi-
lity shift assay (EMSA) were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA).
Culture of normal human epidermal keratinocytes and SV40-
immortalized keratinocytes Human neonatal foreskin keratinocytes
were cultured in serum-free keratinocyte growth medium (Clonetics,
Walkersville, MD) consisting of basal medium MCDB153 supplemented
with 0.5 mg hydrocortisone per ml, 5 ng epidermal growth factor per ml,
5 mg insulin per ml, and 0.5% bovine pituitary extract. The cells in third
passage were used for the experiments. SV40-immortalized keratinocyte
cell line was established from human neonatal foreskin keratinocytes as
described (Miquel et al, 1996) and cultured in 3 : 1 mixture of Dulbecco
minimal Eagle’s medium and Ham’s F12 with 10% fetal bovine serum, 0.4
mg hydrocortisone per ml, and 10 ng epidermal growth factor per ml. The
SV40-immortalized keratinocytes did not show any signs of crisis, and
morphologically showed a homogeneous spindle shape similar to that of
primary cultured keratinocytes. The cells in eighth passage were used for
the experiments.
Measurement of IP-10 secretion Keratinocytes (2104 per well) were
seeded in triplicate into 24-well plates in 1 ml keratinocyte growth
medium, adhered overnight, then the medium was changed to basal
KBM medium (keratinocyte basal medium) depleted of hormones,
growth factors, and bovine pituitary extract, and incubated for 24 h. The
medium was removed and the cells were pretreated with NK-R
antagonists or signal inhibitors for 30 min, then incubated with SP in the
presence or absence of IFN-g at the indicated concentrations for another 24
h. The concentrations of the antagonists or inhibitors were decided on a
basis of the reported IC50 values. The supernatants were assayed for IP-10
by enzyme-linked immunosorbent assay (HyCult Biotechnology, b.v.
Uden, the Netherlands). The sensitivity of the assay was 20 pg per ml.
Reverse transcription^polymerase chain reaction (reverse trans-
cription^PCR) Keratinocytes were incubated as above for 3 h, and the
cellular mRNAwas extracted using a mRNA puri¢cation kit (Pharmacia,
Uppsala, Sweden) according to the manufacturer’s instructions. cDNAwas
made from RNA samples as described (Tjandrawinata et al, 1997). Primers
and conditions for ampli¢cation were as described (Boorsma et al, 1998;
Hiramoto et al, 1998; Lai et al, 2000). The PCR products were analyzed by
electrophoresis on 2.5% agarose gels and stained with ethidium bromide,
viewed by ultraviolet light, and photographed. Densitometric analysis was
performed by scanning the bands into Photoshop and performing
densitometry with NIH Image Software.
Plasmids and transfections The ¢re£y luciferase reporter plasmids
driven by human IP-10 promoter (^525/þ 97 bp relative to the trans-
criptional start site) were constructed by PCR and insertion into pGL3
basic vector (Promega, Madison,WI) as described (Majumder et al, 1998).
Site-speci¢c mutation in IFN-stimulated response element (ISRE) and
two NF-kB binding sites of the human IP-10 promoter were created by
multiple rounds of PCR using appropriate primers with altered bases as
described (Ohmori and Hamilton, 1993). p3xNF-kB1-SV-luc, p3xNF-
kB2-SV-luc, and p3xISRE-SV-luc were constructed by inserting three copies
of proximal NF-kB (NF-kB1) (50 -GCAACATGGGACTTCCCCAGGAAC-
30, with consensus sequences underlined), distal NF-kB (NF-kB2) (50 -
GAGCAGAGGGAAATTCCGTAACTT-30), and ISRE (50 -CGCTTT-
GGAAAGTGAAACCTACCTC-30) from human IP-10 promoter in front of
the heterologous minimal SV40 promoter upstream of ¢re£y luciferase
reporter as described (Ohmori and Hamilton, 1993; Ohmori et al, 1994).
Transient transfections were performed using Lipofectamine Plus reagent
(GIBCO/BRL, Grand island, NY) according to the manufacturer’s protocol.
Keratinocytes were plated in six-well plates and grown to about 80%
con£uence. Twenty-four hours before the transfection, the medium was
changed to basal KBM medium. Keratinocytes were incubated with 1.8 mg
of luciferase construct and 0.2 mg of Rous sarcomavirus b-galactosidase
vector per well in the mixture of KBM, Plus reagent, and lipofectamine for
5 h, and the cells were washed and incubated in KBM for 18 h. Cells were
washed, and pretreated with NK-R antagonists or signal inhibitors in KBM
for 30 min, then treated with SP in the presence or absence of IFN-g at
indicated concentrations for 6 h. Cell extracts were prepared and luciferase
activities were quantitated using a luciferase assay system (Promega). The
same cell extracts were assayed for b-galactosidase activity using
chemiluminescent Galacto-Light kit (Tropix, Bedford, MA). All readings
were taken using a Lumat 9501 luminometer (Berthold, Wildbach,
Germany). The results obtained in each transfection were normalized for
b-galactosidase activity and expressed as relative luciferase activity. The
transfection and incubation were performed on SV40-immortalized
keratinocytes as described above except that serum and growth factor-free
Dulbecco minimal Eagle’s medium/F12 (3 : 1mixture) was used.
Figure1. A scheme for SP-induced signaling pathways leading to
gene expression. DAG, diacylglycerol; NF-AT, nuclear factor of activated
T cells; NF-IL-6, nuclear factor of IL-6; AP-1, activator protein 1; CREB,
cyclic adenosine monophosphate response element-binding protein;
ICAM-1, intercellular adhesion molecule-1; IL-8, interleukin-8; VCAM-1,
vascular cell adhesion molecule-1.
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EMSA The probes used were annealed double-stranded DNA containing
NF-kB1 site, NF-kB2 site, and ISRE from the human IP-10 promoter.
They were labeled by incorporation of [32P]deoxycytidine triphosphate
with Klenow DNA polymerase. For gel shift assays, 2^5 mg of nuclear
protein extracts were incubated at room temperature for 5min with a
mixture containing 6 mM HEPES (pH 7.9), 0.4 mM ethylenediamine
tetraacetic acid, 125 mM KCl, 10% glycerol, 0.05 mg poly dI-dC per ml, 1 mM
dithiothreitol, 2.5 mM sodium pyrophosphate, 1 mM b-glycerophosphate,
1 mM Na3VO4, 10 mM NaF, 50 mg aprotinin per ml, 50 mg leupeptin per ml.
Approximately, 1 ng labeled probe was added and the reactions were
incubated at room temperature for another 20 min. In antibody supershift
experiments, the nuclear extracts were preincubated with various anti-
bodies on ice for 30 min before the addition of probe. Reactions
were then fractionated on a nondenaturing 5% polyacrylamide gel in
0.5TBE (25 mM Tris, 0.5 mM Na3 EDTA, 24.25 mM boric acid). The gels
were dried and visualized with PhosphorImager (Molecular Dynamics,
Sunnyvale, CA).
RESULTS
The e¡ects of SP on IP-10 secretion in keratinocytes The
constitutive IP-10 secretion with medium alone was minimal in
keratinocytes (mean7SEM 5176 pg per ml, n¼ 5), and IFN-g
enhanced the IP-10 secretion in a concentration-dependent
manner: (i) 98710 pg per ml by IFN-g 0.1 ng per ml; (ii)
293732 pg per ml by IFN-g 1 ng per ml; (iii) 17807212 pg
per ml by IFN-g 10 ng per ml (n¼ 5); and (iv) more than 10 ng
per ml of IFN-g did not further increase the IP-10 secretion. SP
alone did not alter the IP-10 secretion, but SP enhanced the IP-10
secretion induced by suboptimal concentrations of IFN-g (0.1 and
1 ng per ml) (Fig 2a); the signi¢cant e¡ect of SP was revealed at
0.1 nM, and increased in a concentration-dependent manner and
maximized at 10 nM, whereas at 100 nM the stimulatory e¡ect of
SP was reduced. Such bell-shaped dose^responses to SP have
been observed in other studies (Quinlan et al, 1998, 1999b), and
may be caused by receptor desensitization by higher concen-
trations of SP. Thus 10 nM of SP appeared to be the optimal
concentration for the enhancement of IP-10 secretion in synergy
with IFN-g. SP, 10 nM, potentiated IP-10 secretion induced by
IFN-g (0.1 or 1 ng per ml), 5.1-fold or 5.2-fold of controls,
respectively. On the other hand, SP did not further enhance the
IP-10 secretion induced by a saturating concen-tration of IFN-g
(10 ng per ml). Thus SP enhanced IP-10 secretion in synergy with
suboptimal concentrations of IFN-g. As normal human keratino-
cytes express NK-1R and NK-2R but not NK-3R (Song et al,
2000), we examined which NK-R(s) may be involved in the
enhancement of IP-10 production by SP. The synergistic e¡ect
of SP on IFN-g-induced IP-10 secretion was inhibited by the
preincubation with NK-1R antagonist GR82334 but not by
NK-2R antagonist MEN10207 or NK-3R antagonist [Typ7,b-
Ala8]neurokinin A-(4^10) (Fig 2b). This indicates that the e¡ects
of SP on keratinocytes may be mediated via NK-1R. We then
examined if SP may enhance IP-10 mRNA expression induced
by suboptimal concentrations of IFN-g.
The e¡ects of SP on IP-10 mRNA expression A suboptimal
concentration (1 ng per ml) of IFN-g modestly increased IP-10
mRNA level (Fig 3). Though SP alone did not increase the IP-
10 mRNA level, SP increased the IP-10 mRNA level induced by
1 ng per ml IFN-g 3.5-fold, and the e¡ect of SP was inhibited by
the NK-1R antagonist, GR82334 (Fig 3). These results paralleled
those in IP-10 secretion (Fig 2), and also suggest that the synergy
of SP with IFN-g may occur at a pretranslational level in IP-10
synthesis.We then examined if SP may enhance IP-10 promoter
activity induced by suboptimal concentrations of IFN-g.
The e¡ects of SP on IP-10 promoter activity We transiently
transfected human IP-10 promoter-luciferase reporter constructs
into keratinocytes, and the promoter activity was assessed by the
relative luciferase activities of the cell lysates. IFN-g (1 ng per ml)
increased wild-type IP-10 promoter activity 4.1-fold of controls
(Fig 4b, uppermost four columns). SP alone minimally increased
the IP-10 promoter activity, but synergistically enhanced the
promoter activity induced by IFN-g (1 ng per ml). IFN-g (0.1 ng
per ml), moderately increased the wild-type IP-10 promoter
activity 2.5-fold of controls, and the promoter activity by SP
10 nM plus IFN-g at 0.1 ng per ml was 9.5-fold of controls,
indicating the synergistic e¡ect of SP. In contrast, SP did not
further increase the IP-10 promoter activity induced by the
saturating concentration of IFN-g; fold increase by IFN-g (10 ng
per ml) was 25.8-fold and that by IFN-g (10 ng per ml) plus SP
10 nM was 26.0-fold. Thus SP enhanced IP-10 promoter activity
in synergy with suboptimal concentrations of IFN-g. The
e⁄ciency of transfection into keratinocytes by the lipofectamine
method was low (mean7SEM 10.571.3%; n¼ 9) as determined
by £ow cytometry using b-galactosidase vector. It is thus possible
that the results above may re£ect the reaction of a limited
keratinocyte subpopulation. When the transfection by the same
method was performed on SV40-immortalized human
keratinocytes sharing features of normal human keratinocytes,
the transfection e⁄ciency increased to 28.572.7% (n¼ 9). In
SV40-immortalized keratinocytes transfected with IP-10
promoter, SP enhanced the promoter activity in synergy with
1 ng IFN-g per ml in a manner similar to that in normal
keratinocytes (data not shown). Thus the results on normal
human keratinocytes were reproducible, although associated
Figure 2. Dose-dependency for the e¡ects of SP on IFN-c-induced
IP-10 secretion in human keratinocytes (a) and the inhibition by
NK-1R, NK-2R, or NK-3R antagonists on the e¡ects of SP (b). (a)
Human keratinocytes were cultured with indicated concentrations of SP in
the presence or absence of indicated doses of IFN-g. After 24 h, the culture
supernatants were assayed for IP-10 secretion.Values are mean7SD of tri-
plicate cultures. npo0.05 vs control cultures without SP, by one-way ANOVA
with Dunnett’s multiple comparison test. The data shown in the ¢gure are
representative of ¢ve separate experiments. (b) Keratinocytes were preincu-
bated for 30min with medium alone, or with GR82334, MEN10207, or
[Try7,b-Ala8]neurokinin A-(4^10) (each 10 mM), then incubated with SP
10 nM in the presence or absence of IFN-g (1 ng per ml) for another 24 h.
Values are mean7SEM (n¼ 5). npo0.05 vs control cultures with medium
alone, wpo0.05 vs cultures with IFN-g alone, and zpo0.05 vs cultures with
IFN-g plus SP, by one-way ANOVAwith Sche¡e’s multiple comparison test.
1292 KANDA ANDWATANABE THE JOURNAL OF INVESTIGATIVE DERMATOLOGY
with low transfection e⁄ciency. Further transfection studies were
thus performed on normal human keratinocytes followed by
con¢rming the results in SV40-immortalized keratinocytes.
It is known that IFN-g-induced IP-10 transcription required
the cooperation of ISRE with at least one of the two NF-kB
sites on the IP-10 promoter (Ohmori and Hamilton, 1993;
Ohmori et al, 1997).We thus examined which of these elements
may be responsible for the synergy of SP with IFN-g, using
promoters with mutation in each of these elements. The
mutation of ISRE completely abrogated the IP-10 promoter
induction by IFN-g and the synergistic e¡ect of SP (Fig 4b, the
second four columns), suggesting that ISRE is necessary for both
IFN-g-induced promoter activation and the synergistic e¡ect of
SP with IFN-g. When either NF-kB2 (distal NF-kB site) or
NF-kB1 (proximal NF-kB site) was mutated, the basal promoter
activity was reduced, and the fold-induction by SP plus IFN-g
also decreased, whereas the fold induction by IFN-g alone was
retained. These indicate that both NF-kB sites may be
responsible for the constitutive promoter activity, and also for
the synergy of SP with IFN-g. When both NF-kB2 and NF-
kB1 sites were mutated, basal promoter activity was mostly
abolished and IFN-g-induced activation and synergistic e¡ect of
SP with IFN-g were lost even if ISRE was intact.When SV40-
immortalized keratinocytes were transfected with a series of
mutated promoters, the results were similar to those in normal
keratinocytes (data not shown). These suggest that IFN-g-
induced promoter activation may require at least one of the two
NF-kB sites in addition to ISRE.Thus all of the ISRE, NF-kB2,
and NF-kB1 sites may be involved in the synergistic e¡ect of SP
with IFN-g on IP-10 promoter activation.We then analyzed if SP
may alter the activity of transcription through ISRE, NF-kB2, or
NF-kB1motifs either alone or in synergy with IFN-g.
The e¡ects of SP on transcription through ISRE, NF-jB2,
or NF-jB1 motifs Keratinocytes were transiently transfected
with plasmids containing three repeats of ISRE, NF-kB2, or
NF-kB1 linked to the heterologous minimal SV40 promoter
and luciferase reporter, and were incubated with SP alone or
together with IFN-g (1 ng per ml). The transcriptional activity
through each element was evaluated by the relative luciferase
activity in the lysates of the transfected cells. The enhancerless
SV40 promoter-luciferase vector produced very low background
luciferase activity, which was not altered by SP, IFN-g, either
alone or combination (Fig 5, the lowermost four columns).
SP alone increased the transcriptional activities through NF-kB2
and NF-kB1 motifs, whereas 1 ng per ml of IFN-g did not
increase the constitutive and SP-induced transcriptional acti-
vities through both motifs. The constitutive transcriptional
activity through ISRE was much lower than those through
two NF-kB motifs, and IFN-g enhanced the ISRE activity
in a concentration-dependent manner; 2.3-fold of controls
by 0.1 ng per ml, 5.1-fold by 1 ng per ml, and 16.3-fold by 10 ng
per ml of IFN-g, respectively. SP did not increase the constitutive
and IFN-g-induced transcriptional activities through ISRE.
When transfection was performed on SV40-immortalized kera-
tinocytes, SP also increased the transcriptional activities through
Figure 3. The e¡ects of SP on IFN-c-induced IP-10 mRNA expres-
sion in human keratinocytes. Keratinocytes were preincubated with
medium alone, or with 10 mM GR82334 for 30 min, then incubated with
10 nM SP in the presence or absence of IFN-g (1 ng per ml) for 3 h. RNA
was isolated, and reverse transcription^PCRwas performed. The intensity
of the band for IP-10 was corrected to that for glyceraldehyde-3-phosphate
dehydrogenase (GAPDH). The lower graph shows the corrected intensities
relative to that in control cells cultured with medium alone (set as 1.0). The
results shown in the ¢gure are representative of ¢ve separate experiments.
Figure 4. The e¡ects of SP on the basal or IFN-c-induced activities
of wild-type or mutated IP-10 promoters in human keratinocytes.
(a) Schematic representation of human IP-10 promoter. The locations of
ISRE, NF-kB2, and NF-kB1 are shown with their sequences, and substi-
tuted or deleted bases for mutation are indicated. The nucleotide positions
are relative to the transcriptional start site. (b) Keratinocytes were transi-
ently transfected with wild-type (WT) or mutated human IP-10 promoter
linked to luciferase reporter together with b-galactosidase vector. After
transfection, cells were allowed to recover for 18 h and treated with 10 nM
SP in the presence or absence of IFN-g (1 ng per ml) for 6 h. Cells were
harvested and luciferase and b-galactosidase activities were measured. Re-
lative luciferase activities normalized to b-galactosidase activities were
shown. The data are mean7SEM (n¼ 4). Values at right indicate the fold
induction vs basal promoter activity. npo0.05 vs control values and
wpo0.05 vs values with IFN-g alone, by one-way ANOVA with Sche¡e’s
multiple comparison test.
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NF-kB2 and NF-kB1motifs without altering that through ISRE
in a manner similar to that in normal keratinocytes (data not
shown). Thus SP enhanced the transcriptional activity through
the two NF-kB sites, whereas IFN-g enhanced that through
ISRE, and each e¡ect was independent.We then examined if SP
may alter transcription factor binding to each element either
alone or together with IFN-g.
The e¡ects of SP on transcription factor binding to ISRE,
NF-jB2, or NF-jB1 sites Nuclear extracts were obtained
from keratinocytes incubated with SP and/or IFN-g, and EMSA
was performed using ISRE, NF-kB2, or NF-kB1 probes.
Incubation of keratinocytes with SP alone did not induce the
DNA^protein complexes with the ISRE probe, whereas IFN-g
alone induced the complex with the ISRE probe (Fig 6, the
uppermost panel, lanes 2 and 3). The addition of SP did not
a¡ect the IFN-g-induced complex with the ISRE probe (Fig 6,
the uppermost panel, lane 4). The antibodies against signal
transducer and activator of transcription (STAT) 1a and 48 kDa
ISRE-binding protein (p48) supershifted the IFN-g-induced
complex with the ISRE probe (Fig 6, the uppermost panel,
lanes 5 and 6), indicating the presence of STAT1a and p48 in
the complex. Incubation of keratinocytes with SP alone induced
the DNA^protein complexes associated with NF-kB2 and
NF-kB1 probes (Fig 6, the middle and lowermost panels, lane
2). The addition of IFN-g did not a¡ect the SP-induced
complexes with both NF-kB probes (Fig 6, the middle and
lowermost panels, lane 4). The anti-NF-kB p50 and p65
antibodies supershifted the complexes with NF-kB2 and NF-
kB1 probes (Fig 6, the middle and lowermost panels, lanes 5
and 6), indicating the presence of p50 and p65 in the complexes.
Thus SP induced transcription factor binding to two NF-kB sites
whereas IFN-g induced that to ISRE, and each e¡ect was
independent. Though SP alone induces transcription factor
binding and transcriptional activity at two NF-kB sites on IP-10
promoter, SP per se cannot induce IP-10 promoter activity.
This indicates that the NF-kB activation by SP may be
necessary but insu⁄cient for the IP-10 promoter activation, and
the cooperation with IFN-g-induced STAT-1a/p48 may be
required for the signi¢cant promoter activation.
Figure 5. SP and/or IFN-c-induced activation of transcription
through NF-jB2, NF-jB1, or ISRE motifs. Keratinocytes were transi-
ently transfected with luciferase reporter plasmids driven by NF-kB2, NF-
kB1, or ISRE linked to heterologous SV-40minimal promoter together
with b-galactosidase vector. The cells were allowed to recover for 18 h and
incubated with 10 nM SP in the presence or absence of IFN-g (1 ng per ml)
for 6 h. The cells were then harvested and luciferase and b-galactosidase
activities were assayed. The results are shown as relative luciferase activities
normalized for b-galactosidase activities, and represent mean7SEM
(n¼ 4). Values at right indicate the fold induction vs basal activity.
n po0.05 vs control values with medium alone, by one-way ANOVA with
Sche¡e’s multiple comparison test.
Figure 6. SP and/or IFN-c-induced transcription factor binding to
ISRE, NF-jB2 or NF-jB1 motifs in human keratinocytes. Keratino-
cytes were incubated with 10 nM SP in the presence or absence of 1 ng IFN-
g per ml for 30 min, and nuclear extracts were prepared. The nuclear ex-
tracts were incubated with 32P-labeled oligonucleotides containing NF-
kB2, NF-kB1, or ISRE motifs from human IP-10 promoter. In supershift
assays, antibodies against transcription factors were incubated for 30 min
before the addition of the probe. Arrows indicate the supershifted com-
plexes. The results shown in the ¢gure are representative of four separate
experiments.
Figure 7. The inhibition by several signal inhibitors on the enhance-
ment by SP of IFN-c-induced IP-10 secretion (a), promoter activity
(b), and mRNA expression (c) in human keratinocytes. (a,c) Keratino-
cytes were preincubated with medium alone, or with 50 mM BAPTA-AM,
200 mM PDTC, 1 mM U73122, 1 mM calphostin C, 200 mM SQ22536, 10 mM
PD98059, or 10 mM SB202190 for 30 min, then incubated with 10 nM SP in
the presence or absence of 1 ng IFN-g per ml. IP-10 secretion was analyzed
after 24 h, or RNA was extracted after 3 h. (b) Keratinocytes were transi-
ently transfected with human IP-10 promoter linked to luciferase reporter
plasmid, and recovered for 18 h, and incubated as above. After 6 h, luciferase
activities of the cell lysates were analyzed and were normalized for b-galac-
tosidase activities. (a,b) Values are mean7SEM (n¼ 5). npo0.05 vs control
values with medium alone, wpo0.05 vs values with IFN-g alone, and
zpo0.05 vs values with IFN-g plus SP, by one-way ANOVA with Sche¡e’s
multiple comparison test. The results shown in (c) are representative of ¢ve
separate experiments.
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The SP-induced signals required for NF-jB activation and
IP-10 production SP is known to activate a variety of
intracellular signaling pathways (Fig 1), and we aimed to know
which of the signals may be responsible for the SP-induced
NF-kB activation and resultant enhancement of IP-10 synthesis
in synergy with IFN-g. Keratinocytes were preincubated with
several signal inhibitors, then incubated with SP in the presence
of IFN-g (1 ng per ml). Intracellular Ca2þ chelator BAPTA-AM,
anti-oxidant PDTC, and phospholipase C inhibitor U73122
inhibited the enhancement by SP on IFN-g-induced IP-10
secretion (Fig 7a), mRNA expression (Fig 7c), and promoter
activation (Fig 7b). In contrast, protein kinase C inhibitor
calphostin C, adenylate cyclase inhibitor SQ22536, p42/44
mitogen-activated protein kinase inhibitor PD98059, or p38
mitogen-activated protein kinase inhibitor SB202190 did not
suppress the e¡ects of SP.When IP-10 promoter was transfected
into SV40-immortalized keratinocytes, the e¡ects of signal
inhibitors on SP plus IFN-g-induced promoter activation were
similar to those in normal keratinocytes (data not shown). These
suggest that phospholipase C activity, Ca2þ signal, and ROI
formation may be responsible for the enhancement by SP on
IFN-g-induced IP-10 synthesis. On the other hand, the e¡ect of
SP may not involve the activation of protein kinase C, adenylate
cyclase, p42/44, or p38 mitogen-activated protein kinases. We
then analyzed if the above-mentioned signal inhibitors may
suppress the SP-induced NF-kB activation. SP plus IFN-g-
induced enhancement of NF-kB2 or NF-kB1 transcriptional
activity was abrogated by BAPTA-AM, PDTC, and U73122, and
not by calphostin C in normal human keratinocytes (Fig 8a) and
in SV40-immortalized keratinocytes (data not shown), which
paralleled the inhibition on IP-10 synthesis. SP plus IFN-g-
induced transcription factor binding to NF-kB2 or NF-kB1
probes was inhibited by BAPTA-AM, PDTC, and U73122
(Fig 8b, lanes 3, 4, and 5) but not by calphostin C (Fig 8b,
lane 6). These results suggest that SP-induced NF-kB activation
may require phospholipase C activity, Ca2þ signal, and ROI
formation.
DISCUSSION
In this study, SP enhanced IFN-g-induced IP-10 transcription via
NF-kB activation in human keratinocytes. Transfection into nor-
mal human keratinocytes using lipofectamine was associated
with low transfection e⁄ciency (11%). All the results of transfec-
tion studies in normal keratinocytes, however, could be re-
produced in SV40-immortalized keratinocytes with higher trans-
fection e⁄ciency (29%) and sharing features of normal human
keratinocytes. These suggest that the results in transfection studies
on normal human keratinocytes may re£ect the reaction by a
considerable population of keratinocytes. We are now testing if
the results can also be reproduced in normal keratinocytes trans-
fected by a method using E¡ectene (Zellmer et al, 2001) with
higher transfection e⁄ciency (41%).
SP-induced NF-kB activation required Ca2þ and ROI as sec-
ond messengers. Our results are consistent with the previous re-
port; SP increased interleukin-8 expression via NF-kB activation
in human astrocytomaU373 MG cells dependently on the second
messengers above (Lieb et al, 1997). It is supposed that ROI may
induce certain tyrosine kinase(s) to tyrosine-phosphorylate inhi-
bitory NF-kB (IkB)-a, which may dissociate IkB-a from inac-
tive IkB-a-NF-kB complex, leading to the nuclear translocation
and DNAbinding of active free NF-kB p65/p50 (Imbert et al, 1996;
Kang et al, 2000). ROI include superoxide, hydrogen peroxide,
hydroxyl radical, or lipid peroxide (Shi et al, 1999), and certain
enzymes to generate ROI, such as superoxide-generating
NADPH oxidase, are activated by Ca2þ signal (Tauber, 1987). It
is reported that SP induces Ca2þ mobilization from intracellular
store via phospholipase C in keratinocytes (Koizumi et al, 1994;
Mochizuki-Oda et al, 1994; Li et al, 1997). It is thus hypothesized
that SP-induced Ca2þ signal may induce NF-kB activation
via ROI formation in keratinocytes. This possibility should be
investigated further.
Phospholipase C generates diacylglycerol, which activates pro-
tein kinase C (Fig 1). It is known that protein kinase C directly or
indirectly induces the serine phosphorylation and degradation of
IkB-a and resultant NF-kB activation (Imbert et al, 1996). In SP-
stimulated keratinocytes, however, protein kinase C-independent
pathways appeared to activate predominantly NF-kB.
SP preferentially binds to NK-1R, but neurokinin receptors
are promiscuous and SP interacts with NK-2R in murine kerati-
nocytes (Song et al, 2000; Burbach et al, 2001). Furthermore, a
non-neurokinin receptor for SP has been detected in monocytes
(Kavelaars et al, 1994), and receptor-independent action of SP has
also been reported (Kavelaars et al, 1993). At least in human kera-
tinocytes, however, SP appears to act predominantly through
NK-1R. Burbach et al (2001) also reported that SP induced nerve
growth factor production in human keratinocytes mainly via
NK-1R.
SP potently activated NF-kB, but SP alone only minimally in-
duced IP-10 promoter, and IFN-g-induced p48/STAT1a activa-
tion was required for the promoter activation by SP to occur.
IFN-g induces the tyrosine phosphorylation and homodimeriza-
tion of STAT1a, which combines with p48, and is directed to
ISRE (Bluyssen et al, 1995). Possibly NF-kB p65/p50 bound
to two NF-kB sites may cooperate with p48/STAT1a bound to
ISRE on IP-10 promoter and synergistically enhance the tran-
scription. Such cooperation between NF-kB site and IFN-re-
sponsive element occurs in the expression of intercellular
adhesion molecule-1, interferon-regulatory factor-1 (Ohmori
et al, 1997), or major histocompatibility complex class I heavy chain
(Johnson and Pober, 1994). The cooperation between NF-kB and
Figure 8. The inhibition by several signal inhibitors on SP plus
IFN-c-induced transcriptional activities (a) or DNA binding (b) of
NF-jB. (a) Keratinocytes were transiently transfected with luciferase re-
porter vectors driven by NF-kB2 or NF-kB1 motifs linked to minimal
SV40 promoter together with b-galactosidase vector. Cells were preincu-
bated with medium alone, or with 50 mM BAPTA-AM, 200 mM PDTC, 1
mM U73122, or 1 mM calphostin C (CalC) for 30 min, then incubated with
10 nM SP plus 1 ng IFN-g per ml for 6 h. Luciferase activities of the cell
lysates were analyzed and normalized for b-galactosidase activities. The
data are mean7SEM (n¼ 5). npo0.05 vs control values with medium
alone, and wpo0.05 vs values with SP alone, by one-way ANOVAwith Schef-
fe’s multiple comparison test. (b) Keratinocytes were preincubated with
agents above, then incubated with 10 nM SP plus 1 ng IFN-g per ml. After
30 min, nuclear extracts were obtained and analyzed for EMSA using
NF-B2 or NF-B1 probes. The results shown in the ¢gure are representative
of ¢ve separate experiments.
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STAT1amay be mediated by the summing up of the interaction
of individual transcription factors with basal transcriptional com-
ponents such as TATA-binding protein. Such multiprotein inter-
actions may facilitate the assembly of a pre-initiation complex,
and thus promote the transcriptional initiation and elongation
(Sauer et al, 1995). Alternatively, the transcriptional synergy may
be mediated by the direct interaction of NF-kB and STAT1a,
which may stabilize the DNA binding of individual transcription
factors and thus create a highly stable multiprotein complex
(Thanos and Maniatis, 1995). As IFN-g alone activated IP-10
promoter via ISRE, IP-10 promoter activity may predominantly
depend on ISRE in human keratinocytes. The mutation of
both NF-kB sites, however, abrogated the response to IFN-g,
although ISRE was intact. This is possibly because the mutation
of two NF-kB sites changed the conformation of IP-10 promoter
and interfered with the p48/STAT1a binding or transcriptional
activity or because the mutation disrupted the constitutive
binding of NF-kB and abrogated its constitutive cooperation
with STAT1a.
This study showed that SP in vitro enhanced IP-10 synthesis in-
duced by suboptimal concentrations of IFN-g in human kerati-
nocytes. Thus SP may in vivo potentiate the e¡ect of low levels
of endogenous IFN-g, possibly derived from T helper 1 cells in-
¢ltrating into in£ammatory skin lesions such as contact dermati-
tis or photodermatitis as well as psoriasis. The in vitro e¡ects of SP,
however, may not be signi¢cantly manifested in vivo as SP is ra-
pidly metabolized in tissues. Further studies should elucidate if
direct cutaneous injection of SP may in vivo enhance IP-10 synth-
esis in synergy with IFN-g.
This work was supported in part by an aid from KANAE Medical Research
Foundation.
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